Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium South Korea
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Aichi Gakuin University (AGU)
- Ajou University (AJOU)
- Blood Systems Research Institute (BSRI)
- China Medical University (CMU)
- Chinese Center for Disease Control and Prevention (China CDC)
- Chubu Rosai Hospital
- Ewha Womans University (Ewha)
- Genome Institute of Singapore (GIS), A*STAR
- Hallym University
- Harvard University
- Institute of Biomedical Sciences (IBMS), Academia Sinica
- Kindai University
- Kyushu University
- Nagoya University
- National Center for Global Health and Medicine (NCGM)
- National Taiwan University (NTU)
- National Taiwan University Hospital (NTUH)
- National University of Singapore (NUS)
- RIKEN Center for Integrative Medical Sciences (IMS)
- Seoul National University (SNU)
- Shanghai Cancer Institute (SCI) at Renji Hospital, SJTU
- Shanghai Jiao Tong University (SJTU)
- Singapore Eye Research Institute (SER), SNEC
- Singapore National Eye Centre (SNEC)
- Soongsil University
- South Korea Ministry of Health and Welfare (MOHW)
- The Chinese University of Hong Kong (CUHK)
- The University of Melbourne (UniMelb)
- The University of North Carolina at Chapel Hill (UNC)
- The University of Tokyo (UTokyo)
- University of San Carlos (USC)
- Vanderbilt University Medical Center (VUMC)